Novolog and Eylea drug interactions - from FDA reports
Drug interactions are reported among people who take Novolog and Eylea together. This review analyzes the effectiveness and drug interactions between Novolog and Eylea. It is created by eHealthMe based on reports of 29 people who take the same drugs from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jul, 22, 2017
29 people who take Novolog, Eylea are studied.
Number of reports submitted per year:
Most common drug interactions over time *:
< 1 month:
1 - 6 months:
6 - 12 months:
1 - 2 years:
Most common drug interactions by gender *:
Most common drug interactions by age *:
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you take Novolog and Eylea?
Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. (latest outcomes from Novolog 25,623 users)
Eylea has active ingredients of aflibercept. It is often used in macular degeneration. (latest outcomes from Eylea 5,438 users)
Interactions between Novolog and drugs from A to Za b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Eylea and drugs from A to Za b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Novolog and Eyleaa b c d e f g h i j k l m n o p q r s t u v w x y z
On eHealthMe, Novolog (insulin aspart recombinant) is often used to treat diabetes. Eylea (aflibercept) is often used to treat age-related macular degeneration. Find out below the conditions the drugs are used for and how effective they are.
What is the drug used for and how effective is it:
- Novolog is used in:
- Eylea is used in: